A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy
Conditions
Multiple System Atrophy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Teva Investigational Site 15554, La Jolla, California, United States
Teva Investigational Site 15545, Los Angeles, California, United States
Teva Investigational Site 15547, Washington D.C., District of Columbia, United States
Teva Investigational Site 15544, Boca Raton, Florida, United States
Teva Investigational Site 15555, Tampa, Florida, United States
Teva Investigational Site 15550, Chicago, Illinois, United States
Teva Investigational Site 15546, Kansas City, Kansas, United States
Teva Investigational Site 15736, Boston, Massachusetts, United States
Teva Investigational Site 15870, Farmington Hills, Michigan, United States
Teva Investigational Site 15552, Rochester, Minnesota, United States
Teva Investigational Site 15549, New York, New York, United States
Teva Investigational Site 15551, New York, New York, United States
Teva Investigational Site 15553, Durham, North Carolina, United States
Teva Investigational Site 15735, Hershey, Pennsylvania, United States
Teva Investigational Site 15548, Pittsburgh, Pennsylvania, United States
Teva Investigational Site 15869, Georgetown, Texas, United States
Teva Investigational Site 15873, Alexandria, Virginia, United States
Teva Investigational Site 15543, Spokane, Washington, United States
Teva Investigational Site 35290, Bordeaux, France
Teva Investigational Site 35289, Marseille, France
Teva Investigational Site 35291, Salpêtrière, France
Teva Investigational Site 35292, Toulouse, France
Teva Investigational Site 32823, Beelitz-Heilstätten, Germany
Teva Investigational Site 32818, Dresden, Germany
Teva Investigational Site 32822, Düsseldorf, Germany
Teva Investigational Site 32825, Kassel, Germany
Teva Investigational Site 32826, Leipzig, Germany
Teva Investigational Site 32824, Marburg, Germany
Teva Investigational Site 32820, München, Germany
Teva Investigational Site 32819, Münster, Germany
Teva Investigational Site 32821, Ulm, Germany
Teva Investigational Site 80203, Haifa, Israel
Teva Investigational Site 80215, Jerusalem, Israel
Teva Investigational Site 80204, Tel Aviv, Israel
Teva Investigational Site 30299, Bologna, Italy
Teva Investigational Site 30297, Catania, Italy
Teva Investigational Site 30298, Milan, Italy
Teva Investigational Site 30294, Padova, Italy
Teva Investigational Site 30296, Roma, Italy
Teva Investigational Site 30295, Salerno, Italy
Teva Investigational Site 84140, Chiba, Japan
Teva Investigational Site 84139, Fuchū, Japan
Teva Investigational Site 84136, Gifu, Japan
Teva Investigational Site 84137, Niigata, Japan
Teva Investigational Site 84138, Sagamihara, Japan
Teva Investigational Site 84141, Sanda-shi, Japan
Teva Investigational Site 84135, Sendai, Japan
Teva Investigational Site 31323, Barcelona, Spain
Teva Investigational Site 31321, Barcelona, Spain
Teva Investigational Site 31324, Barcelona, Spain
Teva Investigational Site 31327, Madrid, Spain
Teva Investigational Site 31320, Pamplona, Spain
Teva Investigational Site 31322, Seville, Spain
Teva Investigational Site 31319, Valencia, Spain
Study leads
Tev Medical Expert, Study Director
Study Director
Teva Branded Pharmaceutical Products R&D LLC